India Competition Commission approves divestment in Sun Pharma, Ranbaxy deal
MLex Summary: The Competition Commission of India, after conducting an assessment, approved the divestment of products under seven brands of Sun Pharmaceutical Industries and Ranbaxy Laboratories to Emcure Pharmaceuticals in connection...To view the full article, register now.
Already a subscriber? Click here to view full article